Kaletra® Lawyer & Lawsuit

Tweet

Breaking News: Kaletra (lopinavir/ritonavir) oral solution may cause serious health problems in premature babies. An increased risk of heart, kidney, and breathing problems is due to one of the main ingredients in the drug (propylene glycol). FDA recommends that the use of Kaletra be avoided unless absolutely necessary.

Free Kaletra Case Evaluation: If your child or other loved one has been injured by Kaletra, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

What’s the problem?

March 8, 2011 – Today, the U.S. Food & Drug Administration (FDA) announced that the label of Kaletra (lopinavir/ritonavir) oral solution is being revised to include a new warning about the serious health problems that have been reported in premature babies after receiving the drug.

Kaletra contains alcohol and propylene glycol, both of which present a risk to premature babies because they have a decreased ability to eliminate propylene glycol. This could lead to adverse events such as serious heart, kidney, or breathing problems.

The FDA is recommending that the use of Kaletra be avoided in premature babies unless a healthcare professional believes that the benefit of using the drug to treat HIV infection immediately after birth outweighs the potential risks. In such cases, FDA strongly recommends monitoring for increases in serum osmolality, serum creatinine, and other signs of toxicity.

Need more info? Get the facts.

If you’d like more information about this drug, please visit the Kaletra website. To learn more about the Kaletra label change, go to the FDA website to view the official press release.

Do I have a Kaletra Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Kaletra lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.